AIDS Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Non-Hodgkin Lymphoma
Phase I Clinical Trial Of SL11047 Commence In AIDS Patients
November 19th, 2001
SLIL Biomedical Corp. announced that the U.S. Food and Drug Administration (FDA) has completed its review of the Investigational New Drug application (IND) for SLIL's candidate drug, SL11047. Phase I human clinical trials with the drug will now commence. The Phase I clinical study, aimed at AIDS-lymphoma patients, will be undertaken by Dr. Lawrence Kaplan at the University of California San Francisco. "This is a vital milestone for SLIL," said Peter Molloy, SLIL. "It takes our company out of the preclinical stage and into the clinical development stage. It has been a formidable learning curve, but we are now ready to confidently push forward with...
Source: AIDS Weekly (2001-11-19)
|
